- Home
- SNCY vs CBLL Comparison
SNCY vs CBLL Comparison
Compare SNCY & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNCY | CBLL |
|---|---|---|
| Founded | 1982 | 2014 |
| Country | United States | United States |
| Employees | N/A | 280 |
| Industry | Air Freight/Delivery Services | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.0M | 750.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SNCY | CBLL |
|---|---|---|
| Price | $16.17 | $18.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $19.50 | ★ $23.20 |
| AVG Volume (30 Days) | ★ 666.7K | 302.0K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | ★ $1,126,769,000.00 | N/A |
| Revenue This Year | $12.27 | $29.57 |
| Revenue Next Year | $7.51 | $28.44 |
| P/E Ratio | $37.60 | ★ N/A |
| Revenue Growth | ★ 4.74 | N/A |
| 52 Week Low | $10.14 | $10.85 |
| 52 Week High | $22.29 | $24.33 |
Technical Indicators
Market Signals| Indicator | SNCY | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 45.66 | 47.46 |
| Support Level | $15.36 | $17.51 |
| Resistance Level | $17.93 | $20.25 |
| Average True Range (ATR) | 0.65 | 0.95 |
| MACD | 0.05 | 0.09 |
| Stochastic Oscillator | 49.16 | 57.34 |
Price Performance
Historical ComparisonAbout SNCY Sun Country Airlines Holdings Inc.
Sun Country Airlines Holdings Inc operates low-cost air carriers. The business has two operating segments: Passenger and Cargo. The passenger segment has two internal passenger groups Scheduled service and Charter. The Cargo segment provides air cargo services. The majority of the revenue is from the passenger segment.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.